微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.67% | -49.24% | 103.03% | 85/142 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.33% | -51.47% | -86.19% | 87/142 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.39% | 1295% | -22.4% | 73/142 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 3.08% | 584.44% | 133.33% | 70/142 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.32% | 1566.67% | 94.12% | 76/142 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.68% | 718.18% | 440% | 83/142 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -0.2% | -106.33% | -144.44% | 98/142 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.45% | -87.32% | 600% | 108/142 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.09% | -103.49% | 18.18% | 106/142 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.11% | -106.01% | -103.48% | 107/142 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 3.16% | -58.42% | -10.99% | 84/142 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.55% | -50.56% | 37.6% | 83/142 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.58% | -38.28% | 40.98% | 72/142 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.83% | -6.15% | -75.92% | 64/142 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 7.6% | -2.81% | 5.85% | 79/142 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 7.18% | 8.3% | 71.77% | 71/142 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.18% | 23.67% | 114.36% | 76/142 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.95% | 1.04% | -75.06% | 71/142 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 7.82% | -4.98% | 17.95% | 93/142 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.63% | -55.2% | 96.15% | 83/142 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.38% | -28.09% | 75.13% | 98/142 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.93% | -24.02% | -76.55% | 76/142 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 8.23% | -63.55% | -44.39% | 98/142 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 14.8% | 2% | 214.89% | 42/142 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.7% | -60.8% | 85.04% | 72/142 | 15.17% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2020-03-31 | 2.54% | 2% | -88.75% | 33/142 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 22.58% | 34.56% | 88.32% | 31/142 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 11.99% | 2% | -28.55% | 14/142 | 6.76% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2018-12-31 | 16.78% | 21.86% | 21.86% | 45/142 | 14.23% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-12-31 | 13.77% | 137800% | 137800% | 49/142 | 14.51% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | -0.01% | 2% | 2% | 75/142 | 16.44% | 安旭生物 | 48.71% | 行业排名> |